356
Views
6
CrossRef citations to date
0
Altmetric
Review

Antibody therapies for multiple myeloma

ORCID Icon, ORCID Icon & ORCID Icon
Pages 295-303 | Received 27 Oct 2019, Accepted 14 Jan 2020, Published online: 22 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou & Evangelos Terpos. (2020) Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection. OncoTargets and Therapy 13, pages 6405-6416.
Read now
Pellegrino Musto & Francesco La Rocca. (2020) Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence. Expert Review of Hematology 13:5, pages 501-517.
Read now

Articles from other publishers (4)

Ioannis Ntanasis-Stathopoulos & Evangelos Terpos. 2022. Bone Cancer. Bone Cancer 1019 1029 .
Anna Y. Aksenova, Anna S. Zhuk, Artem G. Lada, Irina V. Zotova, Elena I. Stepchenkova, Ivan I. Kostroma, Sergey V. Gritsaev & Youri I. Pavlov. (2021) Genome Instability in Multiple Myeloma: Facts and Factors. Cancers 13:23, pages 5949.
Crossref
Martina Kleber, Ioannis Ntanasis-Stathopoulos & Evangelos Terpos. (2021) BCMA in Multiple Myeloma—A Promising Key to Therapy. Journal of Clinical Medicine 10:18, pages 4088.
Crossref
Elena Zamagni, Paola Tacchetti, Paola Deias & Francesca Patriarca. (2020) The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma. Pharmaceuticals 13:12, pages 451.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.